Filing Details

Accession Number:
0001213900-25-003922
Form Type:
13G Filing
Publication Date:
2025-01-14 19:00:00
Filed By:
Alexandra Wood (Canada) Inc.
Company:
Chromocell Therapeutics Corp
Filing Date:
2025-01-15
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Alexandra Wood (Canada) Inc. 0 574,187 9.53%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G


 
Alexandra Wood (Canada) Inc.
 
Signature:/s/ Marc J. Ross
Name/Title:Marc J. Ross, Esq. As Attorney-In-Fact
Date:01/15/2025
Exhibit Information

Exhibit 99.1: Power of Attorney